Company Filing History:
Years Active: 1994-1998
Title: Akira E Takemori: Innovator in Opioid Research
Introduction
Akira E Takemori is a notable inventor based in Edina, MN (US). He has made significant contributions to the field of opioid research, particularly in developing novel peptides and receptor antagonists. His work has implications for pain management and addiction treatment.
Latest Patents
Takemori holds 2 patents that focus on innovative approaches to opioid analgesics. His latest patents include "Des-Tyr dynorphin analogues," which are novel peptides that mimic the activity of endogenous dynorphin. These peptides are designed to enhance the effects of narcotic analgesics and mitigate withdrawal symptoms. Another significant patent involves the use of selective delta opioid receptor antagonists to alleviate tolerance and dependence on opiate analgesics. This approach aims to provide effective treatment for patients suffering from opioid dependence.
Career Highlights
Throughout his career, Takemori has worked with esteemed institutions, including the University of Minnesota. His research has been pivotal in advancing the understanding of opioid mechanisms and developing therapeutic strategies to combat opioid addiction.
Collaborations
Takemori has collaborated with notable colleagues such as Philip S Portoghese and Nancy M Lee. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Akira E Takemori's innovative work in opioid research has the potential to transform pain management and addiction treatment. His contributions through patents and collaborations highlight his commitment to advancing medical science.